These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 28002979)
41. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands. Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653 [TBL] [Abstract][Full Text] [Related]
42. New trends in the prevention and management of community-acquired pneumonia. Postma DF; van Werkhoven CH; Huijts SM; Bolkenbaas M; Oosterheert JJ; Bonten MJ Neth J Med; 2012 Oct; 70(8):337-48. PubMed ID: 23065981 [TBL] [Abstract][Full Text] [Related]
43. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial. Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166 [TBL] [Abstract][Full Text] [Related]
44. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia. Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781 [TBL] [Abstract][Full Text] [Related]
45. Principles of Antibiotic Management of Community-Acquired Pneumonia. Bender MT; Niederman MS Semin Respir Crit Care Med; 2016 Dec; 37(6):905-912. PubMed ID: 27960214 [TBL] [Abstract][Full Text] [Related]
46. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia. Ferrer M; Menendez R; Amaro R; Torres A Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818 [TBL] [Abstract][Full Text] [Related]
47. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia. Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189 [TBL] [Abstract][Full Text] [Related]
48. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620 [TBL] [Abstract][Full Text] [Related]
49. [Duration of treatment and oral administrad on of antibiotics in community acquired pneumonia]. Bernal-Vargas MA; Cortés JA Rev Chilena Infectol; 2016 Apr; 33(2):177-86. PubMed ID: 27314995 [TBL] [Abstract][Full Text] [Related]
50. Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study. Waagsbø B; Tranung M; Damås JK; Heggelund L BMC Pulm Med; 2022 Oct; 22(1):379. PubMed ID: 36242006 [TBL] [Abstract][Full Text] [Related]
51. Empiric therapy of community-acquired pneumonia. Green DS; San Pedro GS Semin Respir Infect; 2000 Sep; 15(3):227-33. PubMed ID: 11052423 [TBL] [Abstract][Full Text] [Related]
52. Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance. Galli L; Montagnani C; Chiappini E; de Martino M Acta Paediatr; 2013 Dec; 102(465):25-33. PubMed ID: 24330270 [TBL] [Abstract][Full Text] [Related]
53. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844 [TBL] [Abstract][Full Text] [Related]
54. The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias. Cunha BA Med Clin North Am; 1995 May; 79(3):581-97. PubMed ID: 7752730 [TBL] [Abstract][Full Text] [Related]
55. Community-acquired pneumonia as an emergency condition. Cillóniz C; Dominedò C; Garcia-Vidal C; Torres A Curr Opin Crit Care; 2018 Dec; 24(6):531-539. PubMed ID: 30239410 [TBL] [Abstract][Full Text] [Related]
56. Impact of a Personalized Audit and Feedback Intervention on Antibiotic Prescribing Practices for Outpatient Pediatric Community-Acquired Pneumonia. Diaz MCG; Handy LK; Crutchfield JH; Cadilla A; Hossain J; Werk LN Clin Pediatr (Phila); 2020 Oct; 59(11):988-994. PubMed ID: 32486840 [TBL] [Abstract][Full Text] [Related]
57. Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study. Mahboub B; Al Zaabi A; Al Ali OM; Ahmed R; Niederman MS; El-Bishbishi R BMC Pulm Med; 2015 Sep; 15():112. PubMed ID: 26424530 [TBL] [Abstract][Full Text] [Related]
58. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors. Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096 [TBL] [Abstract][Full Text] [Related]
59. Diagnostic testing to establish a microbial cause is helpful in the management of community-acquired pneumonia. Skerrett SJ Semin Respir Infect; 1997 Dec; 12(4):308-21. PubMed ID: 9436958 [TBL] [Abstract][Full Text] [Related]
60. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia. Campbell GD Chest; 1999 Mar; 115(3 Suppl):14S-18S. PubMed ID: 10084454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]